Comparative study on the antileishmanial activities of chemically and biologically synthesized silver nanoparticles (AgNPs).

The present study was conducted to investigate the antileishmanial activity of biogenic silver nanoparticles (AgNPs) compared to chemically synthesized AgNPs. A nano dimension size (10-15 nm) biogenic AgNPs was produced and characterized by UV-Vis spectroscopy and X-rays diffraction. The chemically synthesized AgNPs was recovering from our previous study with a nanoparticle (NP) size in the range of 10-40 nm. The antileishmanial activities were investigated through 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide cell viability assay. The infectivity was determined by Giemsa staining of the infected macrophages cells. Nitric oxide (NO) accumulation was measured by Griess reagent using NaNO as a positive control. After 24 h of exposure with nanoparticles (NPs), a concentration-dependent growth inhibition was observed. The IC values were determined against promastigotes of as 19.42 ± 2.76 µg/ml for leaves aqueous extract mediated AgNPs, 30.71 ± 1.91 µg/ml for stem mediated AgNPs and 51.23 ± 2.20 µg/ml for chemically synthesized AgNPs. It was also detected that all types of NPs produced NO at a significant level. However, the production of a high-level of NO in the biologically synthesized NPs activated macrophage cells, infected with promastigotes indicates that NO radicals are mainly responsible for induced cell death and a decrease in the pathogenicity of the parasites. Since, biogenic nanoparticles are cost-effective, eco-friendly, simple to synthesize, and more effective than chemically synthesized silver nanoparticles, therefore, it could be used as a potential alternative for the development of antileishmanial drugs.